Bolt Biotherapeutics, Inc. (BOLT)
3.86
-0.04
(-1.03%)
USD |
NASDAQ |
Sep 08, 16:00
3.87
+0.01
(+0.26%)
Pre-Market: 20:00
Bolt Biotherapeutics Shareholders Equity (Quarterly) : 12.64M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.64M |
| March 31, 2026 | 19.82M |
| December 31, 2025 | 26.50M |
| September 30, 2025 | 32.10M |
| June 30, 2025 | 38.84M |
| March 31, 2025 | 46.81M |
| December 31, 2024 | 57.20M |
| September 30, 2024 | 72.03M |
| June 30, 2024 | 85.86M |
| March 31, 2024 | 104.16M |
| December 31, 2023 | 112.74M |
| September 30, 2023 | 128.26M |
| June 30, 2023 | 142.13M |
| March 31, 2023 | 157.69M |
| Date | Value |
|---|---|
| December 31, 2022 | 171.51M |
| September 30, 2022 | 188.45M |
| June 30, 2022 | 207.97M |
| March 31, 2022 | 228.39M |
| December 31, 2021 | 250.12M |
| September 30, 2021 | 274.91M |
| June 30, 2021 | 295.90M |
| March 31, 2021 | 303.25M |
| December 31, 2020 | 0.349M |
| September 30, 2020 | -74.59M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 31.66M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 40.34M |
| Total Liabilities (Quarterly) | 27.70M |
| Debt to Equity Ratio | 1.711 |
| Current Ratio | 2.614 |
| Net Debt Paydown Yield | 8.32% |